recombinant human luteinizing hormone (r-hLH)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant human luteinizing hormone (r-hLH), covering 2024-08-27 to 2024-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Potential Benefit of r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation Treatment [Phase 4]